(NASDAQ: FLGT) Fulgent Genetics's forecast annual revenue growth rate of 8.11% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Fulgent Genetics's revenue in 2025 is $315,549,000.On average, 5 Wall Street analysts forecast FLGT's revenue for 2025 to be $10,238,184,230, with the lowest FLGT revenue forecast at $9,766,770,252, and the highest FLGT revenue forecast at $10,596,458,854. On average, 5 Wall Street analysts forecast FLGT's revenue for 2026 to be $11,235,417,996, with the lowest FLGT revenue forecast at $10,745,456,583, and the highest FLGT revenue forecast at $11,593,383,496.
In 2027, FLGT is forecast to generate $12,344,554,621 in revenue, with the lowest revenue forecast at $11,829,863,294 and the highest revenue forecast at $12,752,907,320.